πŸ‡ΊπŸ‡Έ FDA
Patent

US 12178811

Methods of treating depressive disorders

granted A61KA61K31/472A61K9/0053

Quick answer

US patent 12178811 (Methods of treating depressive disorders) held by Xenon Pharmaceuticals Inc. expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/472, A61K9/0053, A61P, A61P25/24